isol
human
primari
atii
cell
fibroblast
fb
obtain
human
lung
deidentifi
organ
donor
whose
lung
suitabl
transplant
donat
medic
research
nation
diseas
research
interchang
philadelphia
pa
intern
institut
advanc
medicin
edison
nj
committe
protect
human
subject
nation
jewish
health
deem
research
nonhuman
subject
research
select
donor
reason
lung
function
ratio
histori
clinic
lung
diseas
chest
radiograph
indic
infect
time
ventil
day
sex
age
race
smoke
histori
variabl
select
criteria
modifi
human
atii
cell
isol
method
publish
fang
et
al
briefli
middl
lobe
perfus
lavag
instil
elastas
worthington
lakewood
nj
min
lung
minc
cell
isol
filtrat
partial
purifi
centrifug
discontinu
densiti
gradient
made
optiprep
accur
chemic
scientif
westburi
ny
densiti
posit
select
mac
microbead
human
epitheli
cell
adhes
molecul
miltenyi
biotech
bergisch
gladbach
germani
isol
cell
resuspend
dmem
supplement
fb
mm
glutamin
amphotericin
b
streptomycin
penicillin
g
gibco
life
technolog
rockvil
md
gentamicin
sigmaaldrich
st
loui
mo
cell
plate
cell
cultur
plate
costar
corn
ny
previous
coat
rattail
collagen
rtc
hous
dmem
fb
cultur
medium
chang
dmem
fb
day
dmem
mgml
bsa
day
day
cell
stimul
ngml
rhhgf
ngml
iav
puerto
strain
gift
dr
k
hartshorn
boston
univers
boston
multipl
infect
moi
cell
lysat
cultur
medium
harvest
h
stimul
evalu
effect
pathway
granulocyt
macrophag
colonystimul
factor
gmcsf
secret
aec
dimethyl
sulfoxid
dmso
sigmaaldrich
vehicl
control
egfr
inhibitor
biovis
milpita
ca
ad
aec
cultur
condit
use
experi
result
phenotyp
aec
would
type
ilik
cell
howev
addit
studi
perform
cultur
condit
design
maintain
type
ii
cell
phenotyp
cell
isol
igg
adher
method
remov
macrophag
cultur
mixtur
rtc
matrigel
bd
bioscienc
san
jose
ca
presenc
charcoalstrip
fb
keratinocyt
growth
factor
kgf
bromocycl
amp
dexamethason
human
primari
atii
cell
plate
rtccoat
millicel
insert
pore
size
membran
surfac
area
million
emd
millipor
darmstadt
germani
dmem
fb
cultur
medium
chang
dmem
fb
day
dmem
mgml
bsa
day
fb
isol
deidentifi
donor
lung
atii
cell
describ
human
lung
fb
prepar
explant
minc
human
lung
tissu
cultur
dish
medium
consist
dmem
supplement
fb
mm
glutamin
uml
penicillin
g
streptomycin
amphotericin
b
gentamicin
day
fb
grew
edg
explant
medium
remain
explant
tissu
fragment
remov
adher
cell
grown
confluenc
fb
passag
grown
near
confluenc
frozen
frozen
cell
expand
use
experi
passag
confirm
fb
immunostain
vimentin
thi
cytokeratin
fb
plate
plate
bd
bioscienc
dmem
includ
fb
cultur
day
cell
wash
cultur
anoth
day
dmem
without
serum
follow
day
aec
plate
insert
infect
h
inocul
insert
aec
place
well
plate
fb
apic
ml
dmem
mgml
bsa
basal
ml
dmem
mgml
bsa
cultur
medium
harvest
combin
h
infect
evalu
effect
hgfcmet
pathway
gmcsf
secret
aec
dmso
vehicl
control
nm
tocri
bioscienc
bristol
uk
phosphocmet
inhibitor
ad
human
primari
atii
cell
million
plate
sixwel
cell
cultur
plate
bd
bioscienc
previous
coat
rtc
dmem
fb
cultur
medium
chang
dmem
fb
day
mgml
bsa
day
day
cell
stimul
iav
strain
moi
without
indomethacin
sigmaaldrich
receptor
antagonist
r
system
minneapoli
mn
condit
medium
cm
harvest
h
infect
evalu
effect
cm
aec
infect
hgf
secret
lung
fb
cm
ad
lung
fb
plate
cell
cultur
plate
cultur
medium
harvest
h
measur
hgf
protein
concentr
elisa
evalu
cytokineschemokin
secret
aec
cell
stimul
rhhgf
cm
analyz
milliplex
magnet
human
cytokineschemokin
plex
emd
millipor
eotaxin
granulocyt
colonystimul
factor
gcsf
gmcsf
monocyt
chemotact
regul
activ
normal
cell
express
secret
rant
vascular
endotheli
growth
factor
vegf
fb
growth
factor
fractalkin
growthrel
oncogen
protein
gro
protein
concentr
measur
accord
instruct
manual
human
neutrophil
isol
healthi
donor
previous
describ
accord
approv
institut
review
board
protocol
nation
jewish
health
cell
label
calceinam
hbss
min
wash
hbss
resuspend
krebsring
phosphat
buffer
dextros
krpd
heatinactiv
plateletdeplet
poor
plasma
hippp
chemotaxi
cm
aec
ngml
rhhgf
ngml
ngml
r
system
ngml
rhgmcsf
r
system
nformylmetleuph
sigmaaldrich
nondirect
migrat
krpd
hippp
assess
use
modifi
boyden
chamber
previous
describ
fluoresc
bottom
chamber
measur
everi
min
min
report
fig
arbitrari
unit
min
cultur
medium
collect
h
infect
moi
centrifug
mix
equal
volum
cold
methanol
analysi
mass
spectrometri
ms
quantit
eicosanoid
prostaglandin
thromboxan
leukotrien
hydroxyeicosatetraeno
acid
hete
cm
carri
previous
describ
determin
eicosanoid
either
stimul
hgf
secret
lung
fb
sigmaaldrich
andor
cayman
chemic
ann
arbor
mn
ad
lung
fb
plate
cell
cultur
plate
cultur
medium
harvest
h
measur
hgf
concentr
elisa
realtim
rtpcr
express
level
gene
express
ratio
express
constitut
probe
cyclophilin
b
specif
primer
probe
hgf
cmet
egfr
purchas
appli
biosystem
foster
citi
ca
measur
concentr
hgf
gmcsf
cultur
medium
use
human
hgf
gmcsf
r
system
elisa
elisa
tech
aurora
co
accord
manufactur
instruct
western
blot
analysi
polyacrylamid
gradient
gel
invitrogen
carlsbad
ca
run
trisglycin
buffer
separ
protein
protein
load
normal
gapdh
primari
antibodi
phosphoryl
egfr
egfr
antibodi
abcam
cambridg
data
present
mean
se
oneway
anova
use
compar
differ
two
group
post
hoc
bonferronidunn
test
use
multipl
comparison
howev
cytokin
concentr
baselin
variabl
human
human
data
shown
percentag
maximum
maxim
level
observ
individu
experi
state
figur
legend
statist
analysi
percentag
maximum
repeatedmeasur
anova
use
compar
mean
condit
statist
techniqu
use
instead
standard
anova
sampl
measur
sever
condit
mean
measur
correl
come
sampl
use
repeatedmeasur
anova
allow
model
correl
necessari
standard
error
calcul
correctli
analys
conduct
sa
statist
signific
set
p
preliminari
experi
found
rhhgf
stimul
secret
aec
investig
addit
cytokineschemokin
induc
human
aec
stimul
rhhgf
cytokineschemokin
supernat
aec
stimul
rhhgf
measur
milliplex
magnet
human
cytokineschemokin
plex
gmcsf
strongli
upregul
p
moder
upregul
p
rhhgf
n
fig
maxim
level
stimul
hgf
experi
rang
ngml
vegf
fractalkin
gro
detect
upregul
rhhgf
data
shown
eotaxin
gcsf
detect
low
concentr
detect
data
shown
gmcsf
neutrophil
chemoattract
evalu
whether
aec
stimul
rhhgf
could
acceler
neutrophil
migrat
vitro
rhhgf
attract
neutrophil
cm
aec
stimul
rhhgf
enhanc
neutrophil
migrat
abrog
specif
receptor
inhibitor
n
fig
level
cm
rang
ngml
experi
degre
neutrophil
migrat
correl
posit
concentr
cm
x
fig
addit
previou
genechip
studi
found
human
aec
express
seven
potenti
egfr
ligand
amphiregulin
areg
heparinbind
epiderm
growth
factor
hbegf
express
strongli
moder
other
weakli
howev
rhareg
rhhbegf
stimul
gmcsf
secret
human
aec
data
shown
addit
neuregulin
ligand
egfr
famili
stimul
secret
aec
examin
cell
type
express
egfr
hgf
cmet
measur
mrna
level
human
neutrophil
alveolar
macrophag
am
aec
fb
rtpcr
express
neutrophil
aec
fig
wherea
receptor
egfr
express
aec
lung
fb
fig
n
hgf
express
neutrophil
fb
aec
fig
wherea
receptor
cmet
highli
express
aec
fig
n
therefor
human
lung
vivo
hgfcmet
signal
like
requir
cellcel
commun
aec
fb
neutrophil
bronchial
epitheli
cell
iav
infect
lead
shed
activ
egfr
induc
secret
suppress
ifn
regulatori
factor
irf
secret
therefor
examin
whether
iav
infect
induc
secret
alter
secret
human
aec
human
aec
infect
moi
concentr
medium
measur
elisa
shown
fig
infect
induc
secret
human
aec
h
infect
n
fig
phosphoryl
egfr
min
infect
n
fig
secret
induc
infect
inhibit
egfr
inhibitor
fig
howev
alter
influenzainduc
secret
fig
basal
level
level
detect
elisa
could
detect
chang
basal
level
also
alter
secret
influenzainfect
aec
data
shown
addit
gmcsf
secret
infect
also
evalu
result
milliplex
knew
gmcsf
secret
aec
also
stimul
fig
gmcsf
secret
also
stimul
infect
h
infect
inhibit
fig
interestingli
baselin
gmcsf
secret
aec
inhibit
fig
previou
observ
perform
influenza
strain
propag
chicken
egg
result
confirm
two
strain
pandem
influenza
cal
grown
madindarbi
canin
kidney
cell
result
virus
similar
result
observ
data
shown
insur
reduc
cytokin
product
observ
presenc
egfr
inhibitor
due
decreas
viral
infect
viral
product
measur
presenc
absenc
inhibitor
decreas
viral
product
n
addit
amount
viral
protein
cell
h
inocul
without
egfr
inhibitor
found
rhhgf
increas
gmcsf
secret
aec
fig
human
lung
hgf
express
lung
fb
aec
wherea
hgf
receptor
cmet
express
aec
fig
therefor
hypothes
hgf
secret
fb
would
stimul
gmcsf
secret
aec
influenza
infect
examin
possibl
aec
plate
insert
infect
moi
without
cmet
inhibitor
place
fb
cultur
plate
apic
basal
medium
harvest
combin
h
infect
measur
gmcsf
secret
infect
induc
gmcsf
secret
aec
cocultur
fb
aec
alon
inhibit
n
fig
b
next
evalu
factor
secret
aec
would
stimul
hgf
secret
fb
iav
infect
previou
studi
use
balf
patient
ard
show
hgf
secret
lung
fb
stimul
therefor
aec
infect
without
indomethacin
cyclooxygenas
inhibitor
cultur
medium
collect
h
infect
cm
place
lung
fb
without
hgf
secret
fb
stimul
infect
inhibit
indomethacin
ilra
n
fig
determin
eicosanoid
stimul
infect
aec
arachidon
metabolit
cm
analyz
ms
fig
infect
induc
secret
aec
n
fig
final
determin
whether
andor
stimul
hgf
secret
lung
fb
ad
lung
fb
cultur
medium
harvest
h
hgf
concentr
media
measur
elisa
stimul
hgf
secret
fb
n
fig
ms
analysi
also
show
arachidon
acid
metabolit
induc
influenzainfect
aec
fig
wherea
limit
quantit
studi
done
aec
cultur
rtc
cell
would
differenti
toward
type
phenotyp
would
longer
express
type
ii
marker
studi
cell
maintain
type
ii
cell
phenotyp
type
ii
cell
cultur
lamininrich
matrix
presenc
differenti
factor
condit
hgf
also
stimul
gmcsf
product
fig
howev
basal
level
level
gmcsf
stimul
statist
reduc
egfr
inhibitor
influenza
viru
known
induc
cytokineschemokin
primari
human
aec
regul
neutrophil
accumul
human
lung
howev
whether
induct
regul
rtk
known
studi
identifi
two
rtk
pathway
induc
iav
infect
aec
stimul
product
neutrophil
chemoattract
gmcsf
one
pathway
iav
induc
secret
activ
egfr
aec
pathway
involv
stimul
cmet
aec
hgf
produc
fb
stimul
produc
aec
infect
influenza
play
import
role
recruit
neutrophil
blood
infect
injur
tissu
protein
product
rapidli
induc
wide
rang
stimuli
tumor
necrosi
factor
bacteria
viru
cellular
stress
howev
recent
evid
suggest
airway
epitheli
surfac
signal
egfr
converg
pathway
produc
innat
immun
respons
varieti
infecti
noninfecti
noxiou
stimuli
influenza
viru
infect
bronchial
epitheli
cell
report
shed
egfr
ligand
includ
activ
egfr
turn
induc
studi
first
demonstr
induc
secret
human
aec
fig
influenza
viru
infect
induc
secret
activ
egfr
induc
gmcsf
secret
human
aec
fig
hgfcmet
pathway
play
import
role
variou
injuri
diseas
model
promot
cell
surviv
regener
tissu
suppress
chronic
inflamm
fibrosi
recent
also
shown
rhhgf
hgf
secret
lung
fb
enhanc
wound
closur
human
aec
monolay
although
hgfcmet
pathway
well
recogn
role
regener
aec
human
littl
known
hgfcmet
signal
innat
immun
respons
respiratori
infect
includ
influenza
infect
far
know
three
report
link
cmet
signal
neutrophil
migrat
cmet
inhibit
result
reduc
accumul
neutrophil
wound
site
zebra
fish
rhhgf
stimul
induct
rat
analog
gene
express
hepatocyt
cmet
signal
regul
secret
pancreat
cancer
cell
line
thu
studi
first
show
hgfcmet
signal
regul
gmcsf
human
aec
attract
neutrophil
influenza
viru
infect
aec
activ
pathway
induc
secret
cmet
ligand
hgf
strongli
express
lung
fb
human
aec
fig
examin
effect
hgfcmet
signal
secret
aec
influenza
infect
use
cocultur
system
aec
fb
previou
studi
report
hgf
increas
balf
patient
ard
hgf
secret
fb
induc
result
similar
induct
pathway
aec
lung
fb
influenza
infect
aec
infect
influenza
secret
exogen
stimul
secret
hgf
human
lung
fb
also
test
stabl
biolog
activ
unstabl
precursor
therefor
induct
hgf
cocultur
system
might
observ
influenza
viral
pneumonia
vivo
also
shown
gmcsf
secret
human
aec
stimul
rhhgf
influenza
viru
cmet
egfr
activ
studi
first
demonstr
rhhgf
influenza
viru
infect
induc
gmcsf
secret
human
aec
cmet
egfr
activ
howev
gmcsf
also
report
induc
egfr
activ
trophoblast
cell
keratinocyt
bronchial
epitheli
cell
anoth
growth
factor
kgf
also
enhanc
gmcsf
secret
murin
atii
cell
kgf
enhanc
alveolar
host
defens
gmcsfstimul
macrophag
activ
murin
bacteri
pneumonia
model
addit
gmcsf
produc
murin
primari
atii
cell
tolllik
receptor
signal
play
protect
role
lung
epithelium
gramneg
bacteri
pneumonia
term
hgf
human
monocyt
stimul
rhhgf
also
shown
induc
gmcsf
mrna
level
studi
support
find
term
role
gmcsf
gmcsf
simul
migrat
activ
surviv
neutrophil
site
inflamm
wherea
peripher
lung
gmcsf
regul
termin
differenti
am
critic
pulmonari
surfact
homeostasi
ammedi
innat
host
defens
gmcsf
also
known
protect
iav
infect
postinfluenza
bacteri
pneumonia
activ
am
addit
balf
patient
ard
gmcsf
gcsf
increas
patient
compar
healthi
control
level
gcsf
gmcsf
correl
sever
pulmonari
neutrophilia
ard
therefor
although
gmcsf
induc
neutrophil
migrat
function
gmcsf
may
import
influenza
viral
pneumonia
previou
studi
show
egfr
signal
suppress
secret
bronchial
epitheli
cell
murin
influenza
model
egfr
inhibit
increas
lymphocyt
recruit
result
decreas
viral
infect
howev
result
differ
report
bronchial
epitheli
cell
secret
human
aec
alter
egfr
activ
fig
addit
although
egfr
ligand
areg
hbegf
stimul
secret
bronchial
epitheli
cell
areg
hbegf
highli
express
human
aec
studi
found
areg
hbegf
induc
secret
human
aec
therefor
type
egfr
ligand
stimul
secret
downstream
pathway
regul
egfr
activ
seem
cell
speci
specif
main
fatal
complic
influenza
viru
infect
viral
pneumonia
lead
ard
influenza
viru
target
aec
especi
atii
cell
first
cell
influenza
viru
encount
enter
alveolu
respons
viral
infect
aec
produc
cytokin
attract
neutrophil
key
featur
ard
accumul
neutrophil
lung
releas
chemokin
includ
resid
cell
central
neutrophil
recruit
therefor
target
egfr
andor
cmet
suppress
excess
neutrophil
accumul
subsequ
inflamm
may
potenti
strategi
influenza
virusinduc
ard
howev
sever
critic
issu
limit
first
neutrophil
play
import
role
innat
immun
defens
phagocytos
pathogen
prevent
invas
wherea
excess
accumul
activ
neutrophil
caus
unwant
bystand
tissu
damag
exampl
remov
neutrophil
model
influenza
viru
infect
worsen
outcom
second
cmet
egfr
regul
multipl
function
pathway
regener
damag
airway
epithelium
gmcsf
secret
might
protect
influenzainduc
ard
exampl
egfr
inhibitor
inhibit
basal
wound
closur
human
bronchial
epitheli
cell
antihgf
antibodi
ad
mous
lung
explant
influenza
infect
reduc
alveolar
epitheli
regener
therefor
consid
target
egfr
cmet
suppress
excess
neutrophil
accumul
subsequ
inflamm
potenti
benefit
must
consid
relat
potenti
deleteri
effect
third
investig
rel
import
cmet
egfr
signal
vivo
innat
immun
respons
influenza
viru
infect
pathogenesi
ard
murin
influenza
model
egfr
inhibit
protect
mice
influenza
infect
decreas
infect
increas
leukocyt
migrat
secret
influenzainfect
mice
treat
egfr
inhibitor
decreas
level
murin
homolog
neutrophil
lung
rel
import
cmet
signal
vivo
neutrophil
accumul
influenzainfect
mice
investig
determin
role
hgf
mous
influenza
infect
howev
complic
murin
alveolar
macrophag
express
secret
hgf
wherea
human
alveolar
macrophag
fig
nevertheless
recombin
hgf
stimul
alveolar
prolifer
alveolar
repair
mous
influenza
infect
protect
alveolar
damag
unexpect
find
egfr
inhibit
less
effect
reduc
influenzainduc
secret
aec
cultur
maintain
alveolar
type
ii
cell
phenotyp
assum
addit
parallel
pathway
activ
cell
maintain
type
ii
cell
phenotyp
signific
inhibit
secret
would
requir
inhibit
multipl
pathway
howev
also
possibl
signal
effect
aec
flatten
spread
perhap
pathway
domin
type
cell
type
ii
cell
resolv
issu
requir
isol
human
type
cell
addit
studi
futur
howev
also
indic
studi
bronchial
epitheli
cell
includ
studi
highli
differenti
cell
compar
cell
cultur
tissu
cultur
plastic
summari
studi
first
show
primari
human
aec
induc
gmcsf
cmet
egfr
activ
influenza
infect
activ
cmet
egfr
human
aec
although
studi
vivo
model
necessari
determin
rel
import
cmet
egfr
neutrophil
migrat
influenza
viral
pneumonia
studi
use
primari
human
aec
import
first
step
understand
pathogenesi
influenza
viral
pneumonia
human
futur
determin
signal
pathway
downstream
cmet
egfr
respons
cytokinechemokin
product
epitheli
repair
vivo
influenza
model
might
provid
insight
potenti
therapeut
target
control
excess
neutrophil
accumul
without
dampen
host
defens
influenza
viral
pneumonia
work
support
grant
nation
institut
health
hl
ai
hl
exxonmobil
foundat
conflict
interest
financi
otherwis
declar
author
author
contribut
yi
ccl
rjm
concept
design
research
yi
kc
rlz
rcm
perform
experi
yi
kc
rlz
rcm
analyz
data
yi
rlz
ccl
rcm
rjm
interpret
result
experi
yi
prepar
figur
yi
draft
manuscript
yi
rlz
ccl
rjm
edit
revis
manuscript
yi
kc
rlz
ccl
rcm
rjm
approv
final
version
manuscript
